Here is where I’d invest $10,000 in ASX growth stocks

The following are the 3 ASX stocks where I’d Invest $10,000. Each stock covers a different industry and diversifies the portfolio. They are established businesses and have their own strengths, a good financial performance along with growth potential.

Best ASX Performing Stocks

Lovisa Holdings Limited (ASX: LOV) is an Australian company engaged in retail sale of fashion jewelry and accessories. It has a market capitalization of $3.12B.

LOV reported a 17.6% increase in revenue from FY25 to $938.8M in FY26. In FY26, the company’s gross profit also increased by 18.4% to $775.3M and its gross margin was 82.6%. Its earnings before interest and tax for the year was $158.2M and its net profit after tax was $95.6M representing an increase of 14.1% and 10.7% respectively as compared to previous year.

During FY26, the company opened 160 new stores, closed 43 stores and relocated 12 stores in order to maintain profitable growth and maintain quality global store network. It now has a global network of 1,136 stores across more than 50 markets. This includes 6 new franchise markets opened across Africa and Middle East.

The Group plans to expand and move into new markets while continuing to grow its existing markets. It is also focusing on its online presence and has increased its social media engagement. Further, the company has scheduled the delivery of 28 store for the first half of FY27.

Resmed Inc. (ASX: RMD) works to increase awareness of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. It provides diagnoses and develops treatments for these conditions for people worldwide. The company has a market capitalization of $48B.

For the quarter ended September 2026, RMD reported a net revenue of US$1.414B and a gross profit of US$0.87B. Its net income also surged from US$0.348B in prior corresponding period to US$0.418B in the September 2026 quarter and its basic earnings per share also increased to US$2.93 per share. As at 30 September 2026, the company has a cash balance of US$1.01B.

During the quarter, Resmed invested US$103M on research and development activities. On 1 September 2026, the company completed the sale of its MatrixCare business in order to focus on its core growth areas d sleep, breathing and connected home-based healthcare.

RMD is focusing on the development and commercialization of new, innovative products and solutions in order to improve patient outcomes, create efficiencies for its customers and help physicians and providers better manage chronic disease and lower healthcare costs.

Breville Group Limited (ASX: BRG) is an Australian company engaged in designing and development of small electrical kitchen appliances and the effective marketing and distribution of these products across the globe. It has a market capitalization of $4.86B.

BRG reported a 6.7% increase in revenue from $1696.6M in FY25 to $1810.9M in FY26 followed by a 5% increase in gross profit to $651.4M. Its EBITDA and EBIT for the year were $284.1M and $207M respectively. The company’s net profit after tax was recorded at $138.1M. As at 30 June 2026, the Group’s net cash was $104.4M.

During the year, the company launched new products including Oracle Dual Boiler, EyeQ Toaster, Baratza Encore ESP Pro and Lelit Mara X3. It also saw an exceptional performance across its newer geographical markets with China, Korea, Mexico and the Middle East collectively growing revenue by over 70% in FY26.

The Group is continuing capital investment in its business growth drivers. It is focusing on expanding its stores and enter new markets. The company also made progress in its AI transformation and sees potential for AI in order to further enhance productivity and innovation in FY27.

(Source: Company Announcements)